All the news and talk of healthcare recently has started me thinking; I have not read the healthcare bill, and I don’t have any answers for Congress, but there is one particularity of my experience that I think is worth sharing: I have Type 1 diabetes, and I work for a start-up. For those of you who aren’t intimately familiar...

Great personal news: my piece in Popular Science about anti-CD3 monoclonal antibodies (currently best known as teplizumab) and Type 1 diabetes was just featured on the New Hampshire Public Radio show Word of Mouth. (You can read about the segment, and listen to the interview, here.) It’s always great to get to talk about something...

Do you have a great idea for Type 1 diabetes research? Check out this contest from InnoCentive, which is offering a cash prize of between $2,500 and $5,000 for the best ideas for future projects. The details: This Challenge is asking InnoCentive Solvers to formulate well-defined problems or hypotheses aimed at advancing our knowledge about...

Here’s something I don’t like: the idea that a piece of technology I rely on to keep me alive could somehow kill me. I’m speaking not of Toyotas, but of insulin pumps — according to this piece in the Wall Street Journal, “the Food and Drug Administration said Wednesday it has seen an increasing number of...

Oprah’s program last Thursday, “Diabetes: America’s Silent Killer” began a buzz in diabetes communities, and a roar in some. I follow up my post last week, Oprah Takes On Diabetes — I Still Have a Request, with people’s reactions and a heart-felt plea. Dear Oprah and Gayle, I’m emboldened by...

I’m a huge American Idol fan, and I take my Idol watching seriously.  It’s my version of watching sports on TV.  I attribute my Idol love to my childhood years of watching contests and singing shows with my grandmother, Bashy.  She and I watched a lot of Star Search together.  We watched Barbara Mandrell and the Mandrell Sisters. ...

I’ll admit it: I have a Splenda habit. I’ve tried Stevia, I’ve experimented with agave, but at the end of the day I always find myself back with my little yellow packets. Sucralose = my diabetic addiction. When Splenda first came out, I remember raving about it to my roommate Max, a very smart guy who tended to know...

First, an update to my previous post, which was supposed to be about anti-CD3 monoclonal antibodies but was rudely interrupted when I dropped my pump in the toilet: this was a bad idea. Despite the fact that the pump had spent approximately .3 of a second dipped into the tank, it decided it had a “button error” and stopped...

I just had a feature published in Popular Science that I think might be of interest to others with Type 1. As I’ve mentioned previously on this blog, right after being diagnosed with Type 1 diabetes 9 years ago, I enrolled in a trial for a new drug called an anti-CD3 monoclonal antibody (best known as teplizumab and being studied...

I was excited this week to see news about a few different promising studies- the first regarding algorithmically aided treatment of nighttime low glucose in children in the UK, and the second regarding promising research into hormone-based regeneration of insulin production in Type 1 diabetics. I have only recently started following diabetes-related...